Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of ligo-xylose in preparing medicine for treating enteric function disturbance

A technology of intestinal dysfunction and xylo-oligosaccharide, applied in the direction of drug combination, pharmaceutical formula, medical preparation containing active ingredients, etc. Efficacy of alleviating diarrhea and treating intestinal disorders

Inactive Publication Date: 2005-01-05
北京奥信通科技发展有限公司
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

This often leads to the consumption of a large amount of medicine sources, and antibiotics are commonly used because of abnormal defecation frequency, so intestinal flora disorder is prone to occur in IBS
more difficult to treat

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0007] The xylooligosaccharides involved in this patent application can be purchased from the market, such as the xylooligosaccharides produced by Beijing Aoqi Biological Company.

[0008] The basic production process of xylo-oligosaccharides is roughly as follows: remove impurities from the corncobs, crush them, and then process and wash them with saturated high-temperature steam, and then perform high-pressure cooking on the corn flour after pulping, and the cooked mixture is steam-liquid After separation, add refined hydrolytic enzyme liquid to the liquid, and carry out enzymatic hydrolysis under the action of steam. After 4-8 hours of enzymatic hydrolysis, the mother liquor is sterilized, and then water is added to remove the slag, and then the xylose mother liquor is sterilized. 70% xylooligosaccharide syrup can be obtained by decolorization, precision filtration, ion exchange, and vacuum concentration, and then 95% xylooligosaccharide syrup can be obtained by concentratio...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

An application of oligoxylose in preparing the medicines in the form of powder, pill, capsule, tablet, etc for treating the intestinal function disorder (diarrhea, constipation, etc) is disclosed.

Description

technical field [0001] The invention relates to the application of xylooligosaccharide in the pharmaceutical field. Background technique [0002] Irritable bowel syndrome (IBS) is widely valued because of its high prevalence rate and difficult treatment. It accounts for about 5.6% of the population in China, and this disease is very common in China. The etiology and pathogenesis of IBS are still not completely clear. There is no specific drug for the treatment of this disease so far. This often leads to the consumption of a large amount of medicine sources, and antibiotics are often used because of abnormal defecation frequency, so intestinal flora disorder is prone to occur in IBS. more difficult to treat. [0003] The present invention relates to xylooligosaccharide (xylooligosaccharide), which is also called xylooligosaccharide, and is a functional oligosaccharide formed by combining 2-7 xylose molecules with β (1, 4) glycosidic bonds, wherein the disaccharide It is m...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/702A61P1/14
Inventor 吉朋松
Owner 北京奥信通科技发展有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products